Listed

Seres Therapeutics, Inc.

MCRBNasdaqCIK 1609809HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$736.0k, Q2 FY2026
Operating income−$21.3m, Q2 FY2026
Net income$4.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.3Revenue, Q3 FY2023, three months to 2023-09-30$310.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure(126)Revenue, Q4 FY2023, three months to 2023-12-31−$126.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure0.4Revenue, Q3 FY2025, three months to 2025-09-30$351.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure0.4Revenue, Q4 FY2025, three months to 2025-12-31$438.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.4Revenue, Q1 FY2026, three months to 2026-03-31$358.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.7Revenue, Q2 FY2026, three months to 2026-06-30$736.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Research and development$m25.2Research and development, Q3 FY2023, three months to 2023-09-30$25.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure23.0Research and development, Q4 FY2023, three months to 2023-12-31$23.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure19.5Research and development, Q1 FY2024, three months to 2024-03-31$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure15.8Research and development, Q2 FY2024, three months to 2024-06-30$15.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure16.5Research and development, Q3 FY2024, three months to 2024-09-30$16.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure12.8Research and development, Q4 FY2024, three months to 2024-12-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure11.8Research and development, Q1 FY2025, three months to 2025-03-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure12.9Research and development, Q2 FY2025, three months to 2025-06-30$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure12.6Research and development, Q3 FY2025, three months to 2025-09-30$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure11.7Research and development, Q4 FY2025, three months to 2025-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure13.2Research and development, Q1 FY2026, three months to 2026-03-31$13.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure9.1Research and development, Q2 FY2026, three months to 2026-06-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Operating income$m(44.6)Operating income, Q3 FY2023, three months to 2023-09-30−$44.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure(37.0)Operating income, Q4 FY2023, three months to 2023-12-31−$37.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(34.4)Operating income, Q1 FY2024, three months to 2024-03-31−$34.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure(28.9)Operating income, Q2 FY2024, three months to 2024-06-30−$28.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure(29.2)Operating income, Q3 FY2024, three months to 2024-09-30−$29.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure(28.8)Operating income, Q4 FY2024, three months to 2024-12-31−$28.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(27.2)Operating income, Q1 FY2025, three months to 2025-03-31−$27.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure(24.9)Operating income, Q2 FY2025, three months to 2025-06-30−$24.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure(22.5)Operating income, Q3 FY2025, three months to 2025-09-30−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure(19.4)Operating income, Q4 FY2025, three months to 2025-12-31−$19.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(20.9)Operating income, Q1 FY2026, three months to 2026-03-31−$20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure(21.3)Operating income, Q2 FY2026, three months to 2026-06-30−$21.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Net income$m(47.9)Net income, Q3 FY2023, three months to 2023-09-30−$47.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure(41.2)Net income, Q4 FY2023, three months to 2023-12-31−$41.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(40.1)Net income, Q1 FY2024, three months to 2024-03-31−$40.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure(32.9)Net income, Q2 FY2024, three months to 2024-06-30−$32.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure88.8Net income, Q3 FY2024, three months to 2024-09-30$88.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure(15.6)Net income, Q4 FY2024, three months to 2024-12-31−$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure32.7Net income, Q1 FY2025, three months to 2025-03-31$32.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure(19.9)Net income, Q2 FY2025, three months to 2025-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure8.2Net income, Q3 FY2025, three months to 2025-09-30$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure(15.3)Net income, Q4 FY2025, three months to 2025-12-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(19.9)Net income, Q1 FY2026, three months to 2026-03-31−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure4.6Net income, Q2 FY2026, three months to 2026-06-30$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Diluted EPS$ per share(0.37)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figurenot reported(5.49)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$5.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure(4.34)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$4.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure11.63Diluted EPS, Q3 FY2024, three months to 2024-09-30$11.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figurenot reported3.75Diluted EPS, Q1 FY2025, three months to 2025-03-31$3.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure(2.27)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure0.94Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figurenot reported(2.08)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.47Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Basic EPS$ per share(0.37)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figurenot reported(5.49)Basic EPS, Q1 FY2024, three months to 2024-03-31−$5.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure(4.34)Basic EPS, Q2 FY2024, three months to 2024-06-30−$4.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure11.63Basic EPS, Q3 FY2024, three months to 2024-09-30$11.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figurenot reported3.76Basic EPS, Q1 FY2025, three months to 2025-03-31$3.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure(2.27)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure0.94Basic EPS, Q3 FY2025, three months to 2025-09-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figurenot reported(2.08)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.47Basic EPS, Q2 FY2026, three months to 2026-06-30$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure

Balance sheet

Cash and equivalents$15.6m, Q2 FY2026
Long-term debt$110.0m, Q2 FY2024
Shareholders' equity$34.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m170Cash and equivalents, Q3 FY2023, at 2023-09-30$169.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure128Cash and equivalents, FY2023, at 2023-12-31$128.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0000950170-25-038427.Report this figure111Cash and equivalents, Q1 FY2024, at 2024-03-31$111.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure71.2Cash and equivalents, Q2 FY2024, at 2024-06-30$71.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure66.8Cash and equivalents, Q3 FY2024, at 2024-09-30$66.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure30.8Cash and equivalents, FY2024, at 2024-12-31$30.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-103276.Report this figure58.8Cash and equivalents, Q1 FY2025, at 2025-03-31$58.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure45.4Cash and equivalents, Q2 FY2025, at 2025-06-30$45.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure47.6Cash and equivalents, Q3 FY2025, at 2025-09-30$47.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure45.8Cash and equivalents, FY2025, at 2025-12-31$45.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure29.8Cash and equivalents, Q1 FY2026, at 2026-03-31$29.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure15.6Cash and equivalents, Q2 FY2026, at 2026-06-30$15.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Current assets$m214Current assets, Q3 FY2023, at 2023-09-30$214.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure175Current assets, FY2023, at 2023-12-31$175.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038427.Report this figure165Current assets, Q1 FY2024, at 2024-03-31$165.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure149Current assets, Q2 FY2024, at 2024-06-30$149.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure72.9Current assets, Q3 FY2024, at 2024-09-30$72.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure38.7Current assets, FY2024, at 2024-12-31$38.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-103276.Report this figure66.1Current assets, Q1 FY2025, at 2025-03-31$66.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure48.7Current assets, Q2 FY2025, at 2025-06-30$48.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure51.5Current assets, Q3 FY2025, at 2025-09-30$51.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure49.4Current assets, FY2025, at 2025-12-31$49.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure31.8Current assets, Q1 FY2026, at 2026-03-31$31.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure42.3Current assets, Q2 FY2026, at 2026-06-30$42.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Total assets$m368Total assets, Q3 FY2023, at 2023-09-30$367.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure359Total assets, FY2023, at 2023-12-31$358.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038427.Report this figure341Total assets, Q1 FY2024, at 2024-03-31$341.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure322Total assets, Q2 FY2024, at 2024-06-30$321.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure179Total assets, Q3 FY2024, at 2024-09-30$178.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure140Total assets, FY2024, at 2024-12-31$139.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-103276.Report this figure164Total assets, Q1 FY2025, at 2025-03-31$164.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure144Total assets, Q2 FY2025, at 2025-06-30$143.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure143Total assets, Q3 FY2025, at 2025-09-30$143.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure138Total assets, FY2025, at 2025-12-31$138.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure118Total assets, Q1 FY2026, at 2026-03-31$117.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure102Total assets, Q2 FY2026, at 2026-06-30$101.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Current liabilities$m79.2Current liabilities, Q3 FY2023, at 2023-09-30$79.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure98.7Current liabilities, FY2023, at 2023-12-31$98.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038427.Report this figure98.5Current liabilities, Q1 FY2024, at 2024-03-31$98.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure108Current liabilities, Q2 FY2024, at 2024-06-30$108.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure64.8Current liabilities, Q3 FY2024, at 2024-09-30$64.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure41.2Current liabilities, FY2024, at 2024-12-31$41.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-103276.Report this figure31.3Current liabilities, Q1 FY2025, at 2025-03-31$31.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure30.9Current liabilities, Q2 FY2025, at 2025-06-30$30.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure22.4Current liabilities, Q3 FY2025, at 2025-09-30$22.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure19.3Current liabilities, FY2025, at 2025-12-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure19.3Current liabilities, Q1 FY2026, at 2026-03-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure20.0Current liabilities, Q2 FY2026, at 2026-06-30$20.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Total liabilities$m383Total liabilities, Q3 FY2023, at 2023-09-30$382.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure403Total liabilities, FY2023, at 2023-12-31$403.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0000950170-25-038427.Report this figure401Total liabilities, Q1 FY2024, at 2024-03-31$401.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure409Total liabilities, Q2 FY2024, at 2024-06-30$408.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure155Total liabilities, Q3 FY2024, at 2024-09-30$154.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure126Total liabilities, FY2024, at 2024-12-31$126.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-103276.Report this figure114Total liabilities, Q1 FY2025, at 2025-03-31$113.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure111Total liabilities, Q2 FY2025, at 2025-06-30$110.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure99.8Total liabilities, Q3 FY2025, at 2025-09-30$99.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure94.0Total liabilities, FY2025, at 2025-12-31$94.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure91.1Total liabilities, Q1 FY2026, at 2026-03-31$91.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure67.1Total liabilities, Q2 FY2026, at 2026-06-30$67.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure
Long-term debt$m110Long-term debt, Q3 FY2023, at 2023-09-30$110.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure110Long-term debt, FY2023, at 2023-12-31$110.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-05, accession 0000950170-24-025464.Report this figure110Long-term debt, Q1 FY2024, at 2024-03-31$110.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure110Long-term debt, Q2 FY2024, at 2024-06-30$110.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(15.1)Shareholders' equity, Q3 FY2023, at 2023-09-30−$15.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure(44.9)Shareholders' equity, FY2023, at 2023-12-31−$44.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-103276.Report this figure(59.7)Shareholders' equity, Q1 FY2024, at 2024-03-31−$59.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure(87.1)Shareholders' equity, Q2 FY2024, at 2024-06-30−$87.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure23.9Shareholders' equity, Q3 FY2024, at 2024-09-30$23.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure13.8Shareholders' equity, FY2024, at 2024-12-31$13.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure50.5Shareholders' equity, Q1 FY2025, at 2025-03-31$50.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure33.0Shareholders' equity, Q2 FY2025, at 2025-06-30$33.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure43.7Shareholders' equity, Q3 FY2025, at 2025-09-30$43.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure44.2Shareholders' equity, FY2025, at 2025-12-31$44.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure26.5Shareholders' equity, Q1 FY2026, at 2026-03-31$26.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure34.5Shareholders' equity, Q2 FY2026, at 2026-06-30$34.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure

Cash flow

Operating cash flow−$22.4m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(59.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$59.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-126018. Derived: 9-month figure less the 6-month figure.Report this figure(47.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$47.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(35.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$35.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure(39.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$39.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-103611. Derived: 6-month figure less the 3-month figure.Report this figure(34.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$34.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266011. Derived: 9-month figure less the 6-month figure.Report this figure(38.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$38.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure26.9Operating cash flow, Q1 FY2025, three months to 2025-03-31$26.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure(13.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-334174. Derived: 6-month figure less the 3-month figure.Report this figure2.2Operating cash flow, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266011. Derived: 9-month figure less the 6-month figure.Report this figure(14.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure(16.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure(22.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-334174. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-126018. Derived: 9-month figure less the 6-month figure.Report this figure0.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$877.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$99.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-103611. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$129.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266011. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$181.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-334174. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266011. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-103276. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-334174. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)9.75m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares123Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30122,527,275 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-057805.Report this figure126Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31125,862,975 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055159.Report this figure130Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30129,844,931 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-095821.Report this figure128Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30128,289,871 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-126018.Report this figure7.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-317,305,026 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065173.Report this figure7.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-307,575,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-103611.Report this figure7.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-307,632,242 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure8.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,714,701 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure8.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,743,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure8.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-308,771,519 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266011.Report this figure9.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-319,582,533 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-205434.Report this figure9.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-309,747,138 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure

Shares outstanding: 9.94mShares outstanding, period not labelled, at 2026-08-039,941,261 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-334174.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.